<rss version="2.0"><channel><title>ViroPharma Incorporated - Form 4 SEC Filings</title><link>http://ir.viropharma.com/sec.cfm?sh_auth=0.0.0.ad1dcb691ef81696c0c02ea27e385165</link><description>ViroPharma Incorporated - Form 4 SEC Filings</description><language>en-us</language><generator>Shareholder.com RSS Feed</generator><item><title>BROOKE PAUL A</title><link>http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-7748</link><pubDate>Mon, 25 Feb 2013 05:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-7748</guid><description>BROOKE PAUL A</description></item><item><title>CLAYPOOL WILLIAM D MD</title><link>http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-7754</link><pubDate>Mon, 25 Feb 2013 05:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-7754</guid><description>CLAYPOOL WILLIAM D MD</description></item><item><title>DOUGHERTY MICHAEL R</title><link>http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-7766</link><pubDate>Mon, 25 Feb 2013 05:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-7766</guid><description>DOUGHERTY MICHAEL R</description></item><item><title>LEONE JOHN R</title><link>http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-7777</link><pubDate>Mon, 25 Feb 2013 05:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-7777</guid><description>LEONE JOHN R</description></item><item><title>GLASER ROBERT</title><link>http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-7787</link><pubDate>Mon, 25 Feb 2013 05:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-7787</guid><description>GLASER ROBERT</description></item><item><title>MCHUGH JULIE</title><link>http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-7791</link><pubDate>Mon, 25 Feb 2013 05:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-7791</guid><description>MCHUGH JULIE</description></item><item><title>PIEN HOWARD H</title><link>http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-7794</link><pubDate>Mon, 25 Feb 2013 05:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-7794</guid><description>PIEN HOWARD H</description></item><item><title>BROOKE PAUL A</title><link>http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-5064</link><pubDate>Fri, 08 Feb 2013 05:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-5064</guid><description>BROOKE PAUL A</description></item><item><title>BROOM COLIN MD</title><link>http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-1308</link><pubDate>Mon, 07 Jan 2013 05:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-1308</guid><description>BROOM COLIN MD</description></item><item><title>DOYLE THOMAS F</title><link>http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-1310</link><pubDate>Mon, 07 Jan 2013 05:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.viropharma.com/secfiling.cfm?FilingID=1127602-13-1310</guid><description>DOYLE THOMAS F</description></item></channel></rss>